| Year |
Citation |
Score |
| 2021 |
Warren TK, Kane CD, Wells J, Stuthman KS, Van Tongeren SA, Garza NL, Donnelly G, Steffens J, Gomba L, Weidner JM, Norris S, Zeng X, Bannister R, Cihlar T, Bavari S, et al. Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus. Scientific Reports. 11: 19458. PMID 34593911 DOI: 10.1038/s41598-021-98971-0 |
0.347 |
|
| 2020 |
Iversen PL, Kane CD, Zeng X, Panchal RG, Warren TK, Radoshitzky SR, Kuhn JH, Mudhasani RR, Cooper CL, Shurtleff AC, Nasar F, Sunay MM, Duplantier AJ, Eaton BP, Zumbrun EE, et al. Recent successes in therapeutics for Ebola virus disease: no time for complacency. The Lancet. Infectious Diseases. PMID 32563280 DOI: 10.1016/S1473-3099(20)30282-6 |
0.425 |
|
| 2020 |
Porter DP, Weidner JM, Gomba L, Bannister R, Blair C, Jordan R, Wells J, Wetzel K, Garza N, Van Tongeren S, Donnelly G, Steffens J, Moreau A, Bearss J, Lee E, ... ... Warren TK, et al. Remdesivir (GS-5734) is Efficacious in Cynomolgus Macaques Infected with Marburg Virus. The Journal of Infectious Diseases. PMID 32479636 DOI: 10.1093/Infdis/Jiaa290 |
0.393 |
|
| 2020 |
Warren T, Zumbrun E, Weidner JM, Gomba L, Rossi F, Bannister R, Tarrant J, Reed M, Lee E, Raymond JL, Wells J, Shamblin J, Wetzel K, Donnelly G, Van Tongeren S, et al. Characterization of Ebola Virus Disease (EVD) in Rhesus Monkeys for Development of EVD Therapeutics. Viruses. 12. PMID 31941095 DOI: 10.3390/V12010092 |
0.397 |
|
| 2019 |
Pessi A, Bixler SL, Soloveva V, Radoshitzky S, Retterer C, Kenny T, Zamani R, Gomba G, Gharabeih D, Wells J, Wetzel KS, Warren TK, Donnelly G, Van Tongeren SA, Steffens J, et al. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo. Antiviral Research. 104592. PMID 31473342 DOI: 10.1016/J.Antiviral.2019.104592 |
0.381 |
|
| 2019 |
Espy N, Nagle E, Pfeffer B, Garcia K, Chitty AJ, Wiley M, Sanchez-Lockhart M, Bavari S, Warren T, Palacios G. T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques. Antiviral Research. PMID 31195019 DOI: 10.1016/J.Antiviral.2019.06.001 |
0.39 |
|
| 2019 |
Ward MD, Brueggemann EE, Kenny T, Reitstetter RE, Mahone CR, Trevino S, Wetzel K, Donnelly GC, Retterer C, Norgren RB, Panchal RG, Warren TK, Bavari S, Cazares LH. Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison. Clinical Proteomics. 16: 7. PMID 30774579 DOI: 10.1186/S12014-019-9227-3 |
0.418 |
|
| 2018 |
Blair PW, Keshtkar-Jahromi M, Psoter KJ, Reisler RB, Warren TK, Johnston SC, Goff AJ, Downey LG, Bavari S, Cardile AP. Virulence of Marburg Virus Angola Compared to Mt. Elgon (Musoke) in Macaques: A Pooled Survival Analysis. Viruses. 10. PMID 30469360 DOI: 10.3390/V10110658 |
0.34 |
|
| 2018 |
Reisler RB, Zeng X, Schellhase CW, Bearss JJ, Warren TK, Trefry JC, Christopher GW, Kortepeter MG, Bavari S, Cardile AP. Ebola Virus Causes Intestinal Tract Architectural Disruption and Bacterial Invasion in Non-Human Primates. Viruses. 10. PMID 30241284 DOI: 10.3390/V10100513 |
0.365 |
|
| 2018 |
Coffin KM, Liu J, Warren TK, Blancett CD, Kuehl KA, Nichols DK, Bearss JJ, Schellhase CW, Retterer CJ, Weidner JM, Radoshitzky SR, Brannan JM, Cardile AP, Dye JM, Palacios G, et al. Persistent Marburg Virus Infection in the Testes of Nonhuman Primate Survivors. Cell Host & Microbe. PMID 30173956 DOI: 10.1016/J.Chom.2018.08.003 |
0.41 |
|
| 2017 |
Bixler SL, Bocan TM, Wells J, Wetzel K, Van Tongeren S, Dong L, Lackemeyer N, Donnelly G, Cazares L, Nuss J, Soloveva V, Koistinen K, Welch L, Epstein C, Liang LF, ... ... Warren TK, et al. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus. Antiviral Research. PMID 29289666 DOI: 10.1016/J.Antiviral.2017.12.021 |
0.435 |
|
| 2017 |
Bixler SL, Bocan TM, Wells J, Wetzel K, Van Tongeren S, Lackemeyer N, Donnelly G, Cazares L, Soloveva V, Welch L, Epstein C, Liang LF, Giesing D, Lenk R, Bavari S, ... Warren TK, et al. Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus. Antiviral Research. PMID 29289664 DOI: 10.1016/J.Antiviral.2017.12.020 |
0.43 |
|
| 2017 |
Ma J, Zhang X, Soloveva V, Warren T, Guo F, Wu S, Lu H, Guo J, Su Q, Shen H, Solon E, Comunale MA, Mehta A, Guo JT, Bavari S, et al. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo. Antiviral Research. PMID 29253498 DOI: 10.1016/J.Antiviral.2017.12.008 |
0.435 |
|
| 2017 |
Reisler RB, Yu C, Donofrio MJ, Warren TK, Wells JB, Stuthman KS, Garza NL, Vantongeren SA, Donnelly GC, Kane CD, Kortepeter MG, Bavari S, Cardile AP. Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates. Emerging Infectious Diseases. 23: 1316-1324. PMID 28726603 DOI: 10.3201/Eid2308.170029 |
0.414 |
|
| 2017 |
Zeng X, Blancett CD, Koistinen KA, Schellhase CW, Bearss JJ, Radoshitzky SR, Honnold SP, Chance TB, Warren TK, Froude JW, Cashman KA, Dye JM, Bavari S, Palacios G, Kuhn JH, et al. Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nature Microbiology. 2: 17113. PMID 28715405 DOI: 10.1038/Nmicrobiol.2017.113 |
0.43 |
|
| 2017 |
Siegel D, Hui HC, Doerffler E, Clarke MO, Chun K, Zhang L, Neville S, Carra E, Lew W, Ross BS, Wang Q, Wolfe LC, Jordan R, Soloveva V, Knox JE, ... ... Warren TK, et al. Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses. Journal of Medicinal Chemistry. PMID 28124907 DOI: 10.1021/Acs.Jmedchem.6B01594 |
0.404 |
|
| 2017 |
Jordan R, Hogg A, Warren T, De Wit E, Sheahan T, Lo M, Soloveva V, Weidner J, Gomba L, Feldmann F, Cronin J, Sims A, Cockrell A, Feng J, Trantcheva I, et al. Broad-spectrum Investigational Agent GS-5734 for the Treatment of Ebola, MERS Coronavirus and Other Pathogenic Viral Infections with High Outbreak Potential Open Forum Infectious Diseases. 4: S737-S737. DOI: 10.1093/Ofid/Ofx180.008 |
0.444 |
|
| 2017 |
Warren T, MacLennan S, Mathis A, Giuliano E, Taylor R, Sheridan W. Efficacy of Galidesivir against Ebola Virus Disease in Rhesus Monkeys Open Forum Infectious Diseases. 4: S302-S302. DOI: 10.1093/Ofid/Ofx163.697 |
0.408 |
|
| 2016 |
Harbourt DE, Johnston SC, Pettitt J, Warren TK, Dorman WR. Detection of Ebola Virus RNA through Aerosol Sampling of Animal Biosafety Level 4 Rooms Housing Challenged Nonhuman Primates. The Journal of Infectious Diseases. PMID 28011922 DOI: 10.1093/Infdis/Jiw610 |
0.381 |
|
| 2016 |
Cardile AP, Warren TK, Martins KA, Reisler RB, Bavari S. Will There Be a Cure for Ebola? Annual Review of Pharmacology and Toxicology. PMID 27959624 DOI: 10.1146/Annurev-Pharmtox-010716-105055 |
0.366 |
|
| 2016 |
Warfield KL, Warren TK, Qiu X, Wells J, Mire CE, Geisbert JB, Stuthman KS, Garza NL, Van Tongeren SA, Shurtleff AC, Agans KN, Wong G, Callahan MV, Geisbert TW, Klose B, et al. Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo. Antiviral Research. PMID 27908828 DOI: 10.1016/J.Antiviral.2016.11.019 |
0.41 |
|
| 2016 |
Cardile AP, Downey LG, Wiseman PD, Warren TK, Bavari S. Antiviral therapeutics for the treatment of Ebola virus infection. Current Opinion in Pharmacology. 30: 138-143. PMID 27639220 DOI: 10.1016/J.Coph.2016.08.016 |
0.341 |
|
| 2016 |
Taylor R, Kotian P, Warren T, Panchal R, Bavari S, Julander J, Dobo S, Rose A, El-Kattan Y, Taubenheim B, Babu Y, Sheridan WP. BCX4430 - A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease. Journal of Infection and Public Health. PMID 27095300 DOI: 10.1016/J.Jiph.2016.04.002 |
0.463 |
|
| 2016 |
Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, Larson N, Strickley R, Wells J, Stuthman KS, Van Tongeren SA, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. PMID 26934220 DOI: 10.1038/Nature17180 |
0.468 |
|
| 2016 |
Warren TK, Whitehouse CA, Wells J, Welch L, Charleston JS, Heald A, Nichols DK, Mattix ME, Palacios G, Kugleman JR, Iversen PL, Bavari S. Delayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques. Plos Neglected Tropical Diseases. 10: e0004456. PMID 26901785 DOI: 10.1371/Journal.Pntd.0004456 |
0.428 |
|
| 2015 |
Madrid PB, Panchal RG, Warren TK, Shurtleff AC, Endsley AN, Green CE, Kolokoltsov A, Davey R, Manger ID, Gilfillan L, Bavari S, Tanga MJ. Evaluation of Ebola Virus Inhibitors for Drug Repurposing. Acs Infectious Diseases. 1: 317-26. PMID 27622822 DOI: 10.1021/Acsinfecdis.5B00030 |
0.363 |
|
| 2015 |
Heald AE, Charleston JS, Iversen PL, Warren TK, Saoud JB, Al-Ibrahim M, Wells J, Warfield KL, Swenson DL, Welch LS, Sazani P, Wong M, Berry D, Kaye EM, Bavari S. AVI-7288 for Marburg Virus in Nonhuman Primates and Humans. The New England Journal of Medicine. 373: 339-48. PMID 26200980 DOI: 10.1056/Nejmoa1410345 |
0.403 |
|
| 2015 |
Warren TK, Whitehouse CA, Wells J, Welch L, Heald AE, Charleston JS, Sazani P, Reid SP, Iversen PL, Bavari S. A single phosphorodiamidate morpholino oligomer targeting VP24 protects rhesus monkeys against lethal Ebola virus infection. Mbio. 6. PMID 25670780 DOI: 10.1128/Mbio.02344-14 |
0.42 |
|
| 2015 |
Martins K, Cooper C, Warren T, Wells J, Bell T, Raymond J, Stuthman K, Benko J, Garza N, van Tongeren S, Donnelly G, Retterer C, Dong L, Bavari S. Characterization of clinical and immunological parameters during Ebola virus infection of rhesus macaques. Viral Immunology. 28: 32-41. PMID 25514385 DOI: 10.1089/Vim.2014.0085 |
0.437 |
|
| 2015 |
Warren T, Jordan R, Lo M, Soloveva V, Ray A, Bannister R, Mackman R, Perron M, Stray K, Feng J, Xu Y, Wells J, Stuthman K, Welch L, Doerffler E, et al. Nucleotide Prodrug GS-5734 Is a Broad-Spectrum Filovirus Inhibitor That Provides Complete Therapeutic Protection Against the Development of Ebola Virus Disease (EVD) in Infected Non-human Primates Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv130.02 |
0.445 |
|
| 2014 |
Warren TK, Trefry JC, Marko ST, Chance TB, Wells JB, Pratt WD, Johnson JC, Mucker EM, Norris SL, Chappell M, Dye JM, Honko AN. Euthanasia assessment in ebola virus infected nonhuman primates. Viruses. 6: 4666-82. PMID 25421892 DOI: 10.3390/V6114666 |
0.394 |
|
| 2014 |
Wu TY, Singh M, Miller AT, De Gregorio E, Doro F, D'Oro U, Skibinski DA, Mbow ML, Bufali S, Herman AE, Cortez A, Li Y, Nayak BP, Tritto E, Filippi CM, ... ... Warren TK, et al. Rational design of small molecules as vaccine adjuvants. Science Translational Medicine. 6: 263ra160. PMID 25411473 DOI: 10.1126/Scitranslmed.3009980 |
0.338 |
|
| 2014 |
Kuhn JH, Andersen KG, Bào Y, Bavari S, Becker S, Bennett RS, Bergman NH, Blinkova O, Bradfute S, Brister JR, Bukreyev A, Chandran K, Chepurnov AA, Davey RA, Dietzgen RG, ... ... Warren TK, et al. Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names. Viruses. 6: 3663-82. PMID 25256396 DOI: 10.3390/V6093663 |
0.313 |
|
| 2014 |
Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, Dong L, Retterer CJ, Eaton BP, Pegoraro G, Honnold S, Bantia S, Kotian P, Chen X, Taubenheim BR, et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature. 508: 402-5. PMID 24590073 DOI: 10.1038/Nature13027 |
0.48 |
|
| 2014 |
Kuhn JH, Bào Y, Bavari S, Becker S, Bradfute S, Brauburger K, Rodney Brister J, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, ... ... Warren TK, et al. Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Archives of Virology. 159: 1229-37. PMID 24190508 DOI: 10.1007/S00705-013-1877-2 |
0.44 |
|
| 2013 |
Chang J, Warren TK, Zhao X, Gill T, Guo F, Wang L, Comunale MA, Du Y, Alonzi DS, Yu W, Ye H, Liu F, Guo JT, Mehta A, Cuconati A, et al. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses. Antiviral Research. 98: 432-40. PMID 23578725 DOI: 10.1016/J.Antiviral.2013.03.023 |
0.467 |
|
| 2013 |
Martins KA, Warren TK, Bavari S. Characterization of a putative filovirus vaccine: virus-like particles. Virologica Sinica. 28: 65-70. PMID 23385315 DOI: 10.1007/S12250-013-3306-9 |
0.437 |
|
| 2013 |
Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, ... ... Warren TK, et al. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Archives of Virology. 158: 1425-32. PMID 23358612 DOI: 10.1007/S00705-012-1594-2 |
0.38 |
|
| 2013 |
Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Hensley LE, Honko AN, Jahrling PB, ... ... Warren TK, et al. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Archives of Virology. 158: 301-11. PMID 23001720 DOI: 10.1007/S00705-012-1454-0 |
0.36 |
|
| 2012 |
Kugelman JR, Lee MS, Rossi CA, McCarthy SE, Radoshitzky SR, Dye JM, Hensley LE, Honko A, Kuhn JH, Jahrling PB, Warren TK, Whitehouse CA, Bavari S, Palacios G. Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection. Plos One. 7: e50316. PMID 23209706 DOI: 10.1371/Journal.Pone.0050316 |
0.426 |
|
| 2012 |
Iversen PL, Warren TK, Wells JB, Garza NL, Mourich DV, Welch LS, Panchal RG, Bavari S. Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections. Viruses. 4: 2806-30. PMID 23202506 DOI: 10.3390/V4112806 |
0.443 |
|
| 2012 |
Warren TK, Shurtleff AC, Bavari S. Advanced morpholino oligomers: a novel approach to antiviral therapy. Antiviral Research. 94: 80-8. PMID 22353544 DOI: 10.1016/J.Antiviral.2012.02.004 |
0.397 |
|
| 2011 |
Shurtleff AC, Warren TK, Bavari S. Nonhuman primates as models for the discovery and development of ebolavirus therapeutics. Expert Opinion On Drug Discovery. 6: 233-50. PMID 22647202 DOI: 10.1517/17460441.2011.554815 |
0.366 |
|
| 2011 |
Guo H, Pan X, Mao R, Zhang X, Wang L, Lu X, Chang J, Guo JT, Passic S, Krebs FC, Wigdahl B, Warren TK, Retterer CJ, Bavari S, Xu X, et al. Alkylated porphyrins have broad antiviral activity against hepadnaviruses, flaviviruses, filoviruses, and arenaviruses. Antimicrobial Agents and Chemotherapy. 55: 478-86. PMID 21135183 DOI: 10.1128/Aac.00989-10 |
0.435 |
|
| 2010 |
Warren TK, Warfield KL, Wells J, Swenson DL, Donner KS, Van Tongeren SA, Garza NL, Dong L, Mourich DV, Crumley S, Nichols DK, Iversen PL, Bavari S. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nature Medicine. 16: 991-4. PMID 20729866 DOI: 10.1038/Nm.2202 |
0.478 |
|
| 2010 |
Radoshitzky SR, Dong L, Chi X, Clester JC, Retterer C, Spurgers K, Kuhn JH, Sandwick S, Ruthel G, Kota K, Boltz D, Warren T, Kranzusch PJ, Whelan SP, Bavari S. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. Journal of Virology. 84: 10569-80. PMID 20686043 DOI: 10.1128/Jvi.00103-10 |
0.459 |
|
| 2010 |
Warren TK, Warfield KL, Wells J, Enterlein S, Smith M, Ruthel G, Yunus AS, Kinch MS, Goldblatt M, Aman MJ, Bavari S. Antiviral activity of a small-molecule inhibitor of filovirus infection. Antimicrobial Agents and Chemotherapy. 54: 2152-9. PMID 20211898 DOI: 10.1128/Aac.01315-09 |
0.417 |
|
| 2010 |
Warren T, Warfield K, Wells J, Swenson D, Lovejoy C, Iversen P, Bavari S. Treatment of highly pathogenic filovirus infections using advanced antisense technology Retrovirology. 7. DOI: 10.1186/1742-4690-7-S1-P4 |
0.467 |
|
| 2009 |
Aman MJ, Kinch MS, Warfield K, Warren T, Yunus A, Enterlein S, Stavale E, Wang P, Chang S, Tang Q, Porter K, Goldblatt M, Bavari S. Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral Research. 83: 245-51. PMID 19523489 DOI: 10.1016/J.Antiviral.2009.06.001 |
0.498 |
|
| 2009 |
Swenson DL, Warfield KL, Warren TK, Lovejoy C, Hassinger JN, Ruthel G, Blouch RE, Moulton HM, Weller DD, Iversen PL, Bavari S. Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection. Antimicrobial Agents and Chemotherapy. 53: 2089-99. PMID 19223614 DOI: 10.1128/Aac.00936-08 |
0.473 |
|
| 2009 |
Yunus A, Warren T, Warfield K, Enterlein S, Chang S, Mao H, Aman J, Bavari S, Goldblatt M, Kinch M. Identification of a Small-molecule Antiviral with Broad-spectrum Application to Multiple, Lethal Virus Types Antiviral Research. 82: A74-A75. DOI: 10.1016/J.Antiviral.2009.02.197 |
0.385 |
|
| 2008 |
Grosenbach DW, Jordan R, King DS, Berhanu A, Warren TK, Kirkwood-Watts DL, Tyavanagimatt S, Tan Y, Wilson RL, Jones KF, Hruby DE. Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination. Vaccine. 26: 933-46. PMID 18226434 DOI: 10.1016/J.Vaccine.2007.11.095 |
0.531 |
|
| 2008 |
Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge. Journal of Virology. 82: 3517-29. PMID 18199639 DOI: 10.1128/Jvi.01854-07 |
0.6 |
|
| 2008 |
Chen Y, Harver C, Warren T, Hruby D, Jordan R. Establishment of a Cell-based HTS System for Discovery of Anti-Flavivirus Drugs Antiviral Research. 78: A36. DOI: 10.1016/J.Antiviral.2008.01.066 |
0.471 |
|
| 2007 |
Warren TK, Lund SA, Jones KF, Hruby DE. Comparison of transformation protocols in Streptococcus gordonii and evaluation of native promoter strength using a multiple-copy plasmid. Canadian Journal of Microbiology. 53: 417-26. PMID 17538652 DOI: 10.1139/W07-004 |
0.463 |
|
| 2006 |
Wilson RL, Brown LL, Kirkwood-Watts D, Warren TK, Lund SA, King DS, Jones KF, Hruby DE. Listeria monocytogenes 10403S HtrA is necessary for resistance to cellular stress and virulence. Infection and Immunity. 74: 765-8. PMID 16369036 DOI: 10.1128/Iai.74.1.765-768.2006 |
0.478 |
|
| 2006 |
Bolken TC, Laquerre S, Zhang Y, Bailey TR, Pevear DC, Kickner SS, Sperzel LE, Jones KF, Warren TK, Amanda Lund S, Kirkwood-Watts DL, King DS, Shurtleff AC, Guttieri MC, Deng Y, et al. Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses. Antiviral Research. 69: 86-97. PMID 16343651 DOI: 10.1016/J.Antiviral.2005.10.008 |
0.587 |
|
| 2005 |
Warren TK, Lund SA, Jones KF, Hruby DE. Development of PLEX, a plasmid-based expression system for production of heterologous gene products by the gram-positive bacteria Streptococcus gordonii. Protein Expression and Purification. 40: 319-26. PMID 15766873 DOI: 10.1016/J.Pep.2004.10.019 |
0.51 |
|
| 2002 |
Byrd CM, Bolken TC, Jones KF, Warren TK, Vella AT, McDonald J, King D, Blackwood Z, Hruby DE. Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectors. Vaccine. 20: 2197-205. PMID 12009273 DOI: 10.1016/S0264-410X(02)00144-5 |
0.659 |
|
| 2000 |
Lawrence BP, Warren TK, Luong H. Fewer T lymphocytes and decreased pulmonary influenza virus burden in mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) Journal of Toxicology and Environmental Health - Part A. 61: 39-53. PMID 10990162 DOI: 10.1080/00984100050116771 |
0.378 |
|
| 2000 |
Warren TK, Mitchell KA, Lawrence BP. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung. Toxicological Sciences : An Official Journal of the Society of Toxicology. 56: 114-23. PMID 10869459 DOI: 10.1093/Toxsci/56.1.114 |
0.43 |
|
| Show low-probability matches. |